IL2 Receptor alpha antibody [PC61.5] (PE-Cy7)

Cat# GTX01472-10-100ug

Size : 100ug

Marca : Genetex

Contatta il distributore locale :


Telefono : +1 850 650 7790

Anti-IL2 Receptor alpha antibody [PC61.5] (PE-Cy7) used in Flow cytometry (FACS). GTX01472-10

Host

Rat

Clonality

Monoclonal

Clone Name

PC61.5

Isotype

IgG1

Application

FACS

Reactivity

Mouse
Package
100 μg
View product citations for antibody GTX01472-10 on CiteAb
PRODUCT

Summary

The PC61.5 antibody is specific for mouse CD25, a 55 kDa surface protein also known as the Interleukin-2 Receptor alpha chain, or IL-2R alpha. CD25 may bind IL-2 by itself, although with low affinity and without induction of cell signaling. CD25 is also expressed within a high-affinity complex, along with the IL-2R beta chain (CD122) and the common gamma chain (CD132), to form a signaling receptor complex. Expression of CD25 varies during developmental stages of T and B cells, is induced on activated mature T and B cells, and is present on subsets of dendritic cells. CD25 signaling as part of the IL-2 receptor complex triggers T cell activation and proliferation, as well as modulating the differentiation and function of Th17 cells, T regulatory (Treg) cells, and dendritic cells. The PC61.5 antibody is used as a marker for T cells, B cells and dendritic cell subsets. Expression of CD25, CD4 and the transcription factor Foxp3 is regarded as a phenotypic signature for Treg cells. As such, this antibody is widely used to distinguish Treg cells from naïve or conventional T cells which are CD25. This clone has also been reported for depletion of Treg cells in vivo.

APPLICATION

Application Note

*Optimal dilutions/concentrations should be determined by the researcher.
Application Recommended Dilution
FACS Assay dependent
Not tested in other applications.

PROPERTIES

Form

Liquid

Buffer

10mM NaH₂PO₄, 150mM NaCl, 0.1% Gelatin

Preservative

0.09% Sodium azide

Storage

Store as concentrated solution. Centrifuge briefly prior to opening vial. Store at 4ºC. DO NOT FREEZE. Protect from light.

Concentration

0.2 mg/ml (Please refer to the vial label for the specific concentration.)

Purification

Purified by affinity chromatography
From tissue culture supernatant

Conjugation

Phycoerythrin-Cyanine7 (PE-Cy7)

Note

For laboratory research use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.

Purchasers shall not, and agree not to enable third parties to, analyze, copy, reverse engineer or otherwise attempt to determine the structure or sequence of the product.

TARGET

Cellular Localization

Membrane

Database

DATA IMAGES

Anti-IL2 Receptor alpha antibody [PC61.5] (PE-Cy7) used in Flow cytometry (FACS). GTX01472-10

GTX01472-10 FACS Image

FACS analysis of mouse C57Bl/6 splenocytes using GTX01472-10 IL2 Receptor alpha antibody [PC61.5] (PE-Cy7).
Right panel : co-stained with IL2 Receptor alpha antibody [PC61.5] (PE-Cy7) and Mouse CD4 antibody (APC)
Left panel : co-stained with isotype control and Mouse CD4 antibody (APC)
antibody amount : 0.125 μg (5 μl)

Clone Reference

2012; Anti-IL-7 receptor-α reverses established type 1 diabetes in nonobese diabetic mice by modulating effector T-cell function.
2012; Increased CD8+ T-cell function following castration and immunization is countered by parallel expansion of regulatory T cells.
2012; IL-21 inhibits T cell IL-2 production and impairs Treg homeostasis.
2012; Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model.
2012; Role of CD25+ dendritic cells in the generation of Th17 autoreactive T cells in autoimmune experimental uveitis.
Submit a Reference

REVIEW

There are currently no reviews for IL2 Receptor alpha antibody [PC61.5] (PE-Cy7) (GTX01472-10). Be the first to share your experience with this product.
Clone Reference
2012; Anti-IL-7 receptor-α reverses established type 1 diabetes in nonobese diabetic mice by modulating effector T-cell function.
2012; Increased CD8+ T-cell function following castration and immunization is countered by parallel expansion of regulatory T cells.
2012; IL-21 inhibits T cell IL-2 production and impairs Treg homeostasis.
2012; Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model.
2012; Role of CD25+ dendritic cells in the generation of Th17 autoreactive T cells in autoimmune experimental uveitis.
2008; PD-1-dependent mechanisms maintain peripheral tolerance of donor-reactive CD8+ T cells to transplanted tissue.
2006; Foxp3-expressing CD103+ regulatory T cells accumulate in dendritic cell aggregates of the colonic mucosa in murine transfer colitis.
1986; Dissociation of interleukin 2-dependent and -independent B cell proliferation with monoclonal anti-interleukin 2 receptor antibody.
1985; Similarities between interleukin-2 receptor number and affinity on activated B and T lymphocytes.
1985; Expression of interleukin-2 receptors as a differentiation marker on intrathymic stem cells.
SDS
Sodium Azide.pdf